TSX/FRX (TSX/FRX)

Toronto Stock Exchange: TSX/FRX · CAD

CA$14.8

+0.00 (0.0%)· Recorded snapshot

Market cap	535M
Revenue (ttm)	84.1M
Net income (ttm)	-4.6M
EPS (ttm)	-CA$0.14
P/E (forward)	23.8x
Volume	0
Beta	1.23

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 84.1M
Net income (ttm): -4.6M
EPS (ttm): -CA$0.14
P/E (forward): 23.8x
Market cap: 535M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E23.8

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-18.6

P25 n/aP50 n/aP75 n/a

ROIC-2.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSX/FRX indicators

Market & fundamental data

Available fields

184

Groups with data

Currency

USD

Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-12
Employees	35
Employees change	3
Employees growth	10.34%
Enterprise value	CAD 477.1M
Exchange	Toronto Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1996
Industry	Biotechnology
Is primary listing	No
ISIN number	CA31447P1009
Last earnings date	2026-08-11
Last refreshed	2026-10-29
Last stock split date	2014-09-05
Last stock split type	Reverse
Market cap	CAD 535M
Next earnings date	2026-11-12
Price	CAD 14.78
Price currency	CAD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	tsx/FRX
Website	https://www.fennecpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-0.96%
EV/Sales	5.74x
Forward P/E	23.8x
P/B ratio	8.88x
P/S ratio	6.36x
Price / tangible book value	8.88x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-1.9%
EBITDA margin	-1.72%
Gross margin	93.73%
Operating margin	-1.9%
Pretax margin	-5.24%
Profit margin	-5.49%
Profit per employee	CAD -131,866
Profitable quarters	2
Revenue per employee	CAD 2.4M
ROA	-1.16%
ROA (5Y)	-25.84%
ROCE	-1.77%
ROE	-18.58%
ROIC	-2.59%
SBC / revenue	12.67%
Tax / revenue	0.25%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (QoQ)	754.26%
EPS growth quarters	2
EPS growth years	0
Gross profit growth	85.42%
Gross profit growth (Q)	97.5%
Gross profit growth 3Y	107.55%
Gross profit growth 5Y	218.26%
Net income growth (QoQ)	881.59%
Net income growth quarters	2
Net income growth years	0
OCF growth (QoQ)	-97.9%
Revenue growth	77.83%
Revenue growth (Q)	85.18%
Revenue growth (QoQ)	18.31%
Revenue growth 3Y	108.46%
Revenue growth 5Y	222.41%
Revenue growth quarters	5
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	CAD 143,634
EBIT	CAD -1.6M
EBITDA	CAD -1.5M
EPS	CAD -0.14
Financing cash flow	CAD 34.9M
Gross profit	CAD 78.8M
Income taxes	CAD 210,175
Net borrowing	CAD -27.2M
Net cash flow	CAD 32M
Net income	CAD -4.6M
Operating cash flow minus SBC	CAD -13.4M
Operating income	CAD -1.6M
Revenue	CAD 84.1M
Stock-based compensation	CAD 10.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.16
Book value per share	CAD 1.72
Debt / equity	0
Interest coverage	-1.19
Long-term assets	CAD 6.1M
Long-term liabilities	CAD 30M
Net cash (debt)	CAD 58.6M
Net cash / market cap	10.95%
Net debt / equity	-0.97
Piotroski F-Score	4
Shareholders' equity	CAD 60.3M
Tangible book value	CAD 60.3M
Tangible book value per share	CAD 1.72
Total assets	CAD 107.6M
Total cash	CAD 58.6M
Total debt	CAD 0
Total liabilities	CAD 47.3M
WACC	11.02%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.98
Current assets	CAD 101.4M
Current liabilities	CAD 17.3M
Current ratio	5.85
Inventory turnover	1.62
Net working capital	CAD 26.8M
Quick ratio	5.21
Working capital	CAD 85.4M
Working capital turnover	1.82

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-16.69%
Shareholder yield	-16.69%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	479.61%
10Y return CAGR	19.21%
10Y total return	479.61%
150-day SMA	CAD 12.34
15Y price change	915.81%
15Y return CAGR	16.71%
15Y total return	915.81%
1D price change	0%
1M price change	-1.73%
1M total return	-1.73%
1W price change	0.14%
1W total return	0.14%
1Y price change	19.87%
1Y return CAGR	19.89%
1Y total return	19.87%
20-day SMA	CAD 14.69
200-day SMA	CAD 12.29
20Y price change	-26.03%
20Y return CAGR	-1.5%
20Y total return	-26.03%
3M price change	0.89%
3M total return	0.89%
3Y price change	53.32%
3Y return CAGR	15.31%
3Y total return	53.32%
50-day SMA	CAD 15.15
50-day SMA vs 200-day SMA	50over200
52-week high	CAD 17.64
52-week high date	2026-08-11
52-week low	CAD 7.59
52-week low date	2026-04-13
5Y price change	32.79%
5Y return CAGR	5.84%
5Y total return	32.79%
6M price change	57.23%
6M total return	57.23%
All-time high	CAD 391.50
All-time high date	2001-06-05
All-time low	CAD 0.27
All-time low date	2008-12-09
Average true range (ATR)	CAD 0.56
Average volume	421.8
Beta (5Y)	1.23
Change from 52-week high	-16.21%
Change from 52-week low	94.73%
Change from all-time high	-96.22%
Change from all-time low	5,374.07%
Monthly RSI	57.09
Previous close	CAD 14.78
Price vs 150-day SMA	19.77%
Price vs 20-day SMA	0.63%
Price vs 200-day SMA	20.26%
Price vs 50-day SMA	-2.46%
Relative volume	0.44
RSI	49.92
Sharpe ratio	1
Sharpe ratio (3Y)	0.74
Sharpe ratio (5Y)	0.57
Sortino ratio	1.8
Sortino ratio (3Y)	1.26
Sortino ratio (5Y)	0.89
Volume	0
Weekly RSI	56.77
YTD price change	39.43%
YTD total return	39.43%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	19.8M
Shares change (QoQ)	2.48%
Shares change (YoY)	16.69%
Shares held by insiders	2.97%
Shares held by institutions	26.64%
Short ratio	2.6 days

Deeper analysis on TSX/FRX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSX/FRX report

Is a complete TSX/FRX research report available?

No complete published report is available for tsx/FRX (TSX/FRX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSX/FRX (TSX/FRX)

Price

Financial snapshot

Fair-value bridge

Latest news · TSX/FRX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSX/FRX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSX/FRX

Frequently asked questions